-+ 0.00%
-+ 0.00%
-+ 0.00%

QUINCE THERAPEUTICS : LEERINK PARTNERS ADJUSTS TARGET PRICE TO $68 FROM $4 TO REFLECT 1-FOR-20 REVERSE STOCK SPLIT

Reuters·08/18/2026 10:53:48

Please log in to view news